Volume 55, Issue 3, Pages (March 1999)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 2, Pages (August 2002)
Advertisements

Tiffany Shao, Jordan Weinstein, Serge Jothy, Marc Goldstein 
An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes  Jiamin Teng, Elba A Turbat-Herrera, Guillermo.
Volume 68, Issue 6, Pages (December 2005)
Graft pyelonephritis causing graft failure from de novo AA amyloid
The Case | Diabetic nephropathy in a nondiabetic smoker?
Volume 75, Issue 3, Pages (February 2009)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Yihan Wang, Michael A. Shia, Thomas G. Christensen, Steven C. Borkan 
David J. Nikolic-Paterson, Shuang Wang, Hui Yao Lan 
Volume 55, Issue 4, Pages (April 1999)
Volume 78, Issue 2, Pages (July 2010)
Volume 61, Issue 2, (February 2002)
Hyporeninemic hypoaldosteronism from secondary amyloidosis
C.-W. Tsai, V.-C. Wu, W.-C. Lin, J.-W. Huang, M.-S. Wu
John Keeling, Guillermo A. Herrera  Kidney International 
HIV-1 Buds and Accumulates in “Nonacidic” Endosomes of Macrophages
Non-amyloid fibrils in heavy chain deposition disease
Volume 62, Issue 3, Pages (September 2002)
The layered structure of the articular surface
Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells  Hanne B. Moeller, Mark A. Knepper, Robert.
Volume 77, Issue 9, Pages (May 2010)
An improved method for primary culture of rat podocytes
Volume 77, Issue 9, Pages (May 2010)
Volume 86, Issue 4, Pages (October 2014)
Volume 68, Issue 6, Pages (December 2005)
Lipid redistribution in renal dysfunction
Volume 62, Issue 2, Pages (August 2002)
Volume 57, Issue 2, Pages (October 2000)
Emerging treatments for amyloidosis
Volume 61, Issue 6, Pages (June 2002)
Volume 54, Issue 2, Pages (August 1998)
Takashi Ehara, Hidekazu Shigematsu  Kidney International 
Volume 60, Issue 1, Pages (July 2001)
Volume 73, Issue 11, Pages (June 2008)
Advanced Glycation End Product-Modified β2-Microglobulin is a Component of Amyloid Fibrils of Primary Localized Cutaneous Nodular Amyloidosis  Norihiro.
Myeloma cast nephropathy, direct renal infiltration by myeloma, and renal extramedullary hematopoiesis  S.H. Nasr, B.B. Alobeid, J.A. Otrakji, G.S. Markowitz 
Volume 70, Issue 11, Pages (December 2006)
Proteasome inhibitor-based therapy for antibody-mediated rejection
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Blood pressure targets in hemodialysis patients
Volume 62, Issue 5, Pages (November 2002)
Therapy of relapsing minimal-change disease in adults: a new approach?
An unusual cause of acute renal failure
The Case | Idiopathic hypocomplementemic interstitial nephritis
Only anti-CD133 antibodies recognizing the CD133/1 or the CD133/2 epitopes can identify human renal progenitors  Maria L. Angelotti, Elena Lazzeri, Laura.
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Distribution of postsynaptic density proteins in rat kidney: Relationship to neuronal nitric oxide synthase  Akihiro Tojo, David S. Bredt, Christopher.
Volume 67, Issue 3, Pages (March 2005)
Volume 67, Issue 1, Pages (January 2005)
Apolipoprotein E is Present in Primary Localized Cutaneous Amyloidosis
Volume 80, Issue 7, Pages (October 2011)
Volume 55, Issue 5, Pages (May 1999)
Immunity unmasks APOL1 in collapsing glomerulopathy
Enhanced phagocytic capacity endows chondrogenic progenitor cells with a novel scavenger function within injured cartilage  C. Zhou, H. Zheng, J.A. Buckwalter,
Volume 59, Issue 5, Pages (May 2001)
Volume 80, Issue 10, Pages (November 2011)
Figure 3 Models of monoclonal immunoglobulin-induced glomerulopathies
Volume 72, Issue 4, Pages (August 2007)
Localized bladder amyloidosis mimicking bladder carcinoma
Volume 71, Issue 9, Pages (May 2007)
Amylin deposition in the kidney of patients with diabetic nephropathy
Volume 64, Issue 1, Pages (July 2003)
Leukocyte chemotactic factor 2: A novel renal amyloid protein
Volume 68, Issue 5, Pages (November 2005)
Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status  Kathryn J. Tinckam, Ognjenka Djurdjev, Alex.
Volume 56, Issue 6, Pages (December 1999)
Quiz page December 2003 American Journal of Kidney Diseases
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Volume 55, Issue 3, Pages 899-906 (March 1999) Impaired lysosomal processing of β2-microglobulin by infiltrating macrophages in dialysis amyloidosis  M.A.R. García-García, Àngel Argilés, Annie Gouin-Charnet, Mercè Durfort, José García-Valero, Georges Mourad  Kidney International  Volume 55, Issue 3, Pages 899-906 (March 1999) DOI: 10.1046/j.1523-1755.1999.055003899.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Amyloid criteria: Congo red staining of a β2-microglobulin amyloid deposit observed under light microscopy (A) and under polarized light (B). The publication of this figure in color was made possible by a grant from Gambro Renal Care R&D, Lund, Sweden. Kidney International 1999 55, 899-906DOI: (10.1046/j.1523-1755.1999.055003899.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Amyloid deposit location and β2-microglobulin distribution. (Inset) Methylene blue staining showing the cell distribution around the amyloid fibrils. (a) Electron showing a cell engulfing an amyloid deposit (short thick arrows). Cellular processes are indicated by thin arrows (×18,000). Immunogold labeling with anti-β2-microglobulin antibody showing an extracellular (b) and intracellular (c) location of an amyloid deposit (×27,000). Kidney International 1999 55, 899-906DOI: (10.1046/j.1523-1755.1999.055003899.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Intracellular immunolocalization of β2-microglobulin. No labeling with anti-β2-microglobulin antibody was observed in endoplasmic reticulum (er) (a, ×33,000) nor in the Golgi compartment (g) (b, ×33,000). (c) Double immunolabeling for ×2-microglobulin (15 nm) and lysosome-associated protein (LAMP-1; 10 nm) showing that amyloid fibrils are within the lysosomes (×40,000). (d) Double immunolabeling for β2-microglobulin (15 nm) and CD68 (10 nm) confirming that amyloid fibrils are within the lysosomes and that the cells involved are of macrophage-monocytic lineage (×40,000). Kidney International 1999 55, 899-906DOI: (10.1046/j.1523-1755.1999.055003899.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 Density labeling studies of β2-microglobulin and amyloid P component (APC): Comparison of intracellular and extracellular protein density. It can be observed that extracellular labeling of β2-microglobulin (a, ×27,000) was similar to that observed intracellularly (b, ×27,000), whereas a clear decrease in intracellular APC labeling (d, ×33,000) was observed when comparing with extracellular APC labeling (c ×37,800). Kidney International 1999 55, 899-906DOI: (10.1046/j.1523-1755.1999.055003899.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, 899-906DOI: (10. 1046/j. 1523-1755. 1999 Kidney International 1999 55, 899-906DOI: (10.1046/j.1523-1755.1999.055003899.x) Copyright © 1999 International Society of Nephrology Terms and Conditions